Study finds link between dehumanization and burnout in first responders

One in eight U.S. adults have taken semaglutide (Ozempic, Wegovy) or another GLP-1 agonist, a KFF poll found. Metabolic benefits of semaglutide for weight loss

The FDA’s Cen­ter for Drug Eval­u­a­tion and Re­search on Wednes­day of­fi­cial­ly launched a new cen­ter of ex­cel­lence to bet­ter co­or­di­nate sim­u­la­tion and mod­el­ing work, cov­er­ing

Remibrutinib, an investigational Bruton’s tyrosine kinase (BTK) inhibitor, was safe and efficacious in patients with chronic spontaneous urticaria (CSU), a phase IIb extension study showed.